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2. Introduction 
 
2.1. General introductory remarks and an outline of the thesis 
 
Several chronic illnesses can be traced back to alcohol consumption, sedentary lifestyle, 
unhealthy nutrition and smoking. Smoking, in particular, is a global public health 
problem (Edwards, 2004). Tobacco use is identified as one of the most important risk 
factors for oral cancer, and the relevant WHO resolution (WHA60 A16) also 
encourages “steps to ensure that prevention of oral cancer is an integral part of national 
cancer-control programmes, and to involve oral-health professionals or primary health 
care personnel with relevant training in oral health in detection, early diagnosis and 
treatment” (Petersen, 2008). Oral cancer has a high rate of mortality, and more 
importantly, even if the patient survives, it can have a direct infulence on various oral 
functions like the ability to chew or to speak (Schuster et al., 2012), and also on the 
overall quality of life (Nagy et al., 2013). There were 14.1 million new cancer cases, 8.2 
million cancer deaths and 32.6 million people living with cancer (within 5 years of 
diagnosis) in 2012 worldwide (GLOBOCAN 2012, WHO), which points to the 
outstanding importance of defining the controllable causative factors and devising 
preventive strategies.  
Universities are distinguished venues of research, but also of education, and therefore in 
a university framework one can battle smoking-related oral diseases on two fronts: one 
is that of research where knowledge is produced, and the other is teaching, where it is 
disseminated. The present thesis follows this logic. First, after a review of the literature, 
a piece of clinical research is presented, where it is shown that smoking possibly has a 
permissive effect on the occurrence of severe periodontal disease in psoriatic patients. 
This is followed by the introduction of an educational method developed and introduced 
at our faculty, the Faculty of Dentistry at the University of Szeged. The method, which 
is now part of the curriculum of the faculty and also of other Hungarian and foreign 
dental faculties, was developed to enable dental students to offer tobacco cessation 
counseling by providing both theoretical knowledge and skills training.       
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2.2. Tobacco use and oral health  
 
Tobacco use has been described to have several consequences on the human body, 
including several types of cancer. Of these, lung cancer has been the most common 
cancer in the world for several decades. In 2012, 1.8 million new cases have been 
registered worldwide, which is 12.9% of the incidence of all types of cancer 
(GLOBOCAN 2012, WHO). Cigarette smoking and other ways of tobacco use can be 
associated with approximately 75% of oral cancer cases (Rodriguez et al., 2004). The 
worldwide mortality of oral cancer was 82,000 in 1990, which, by 2010, reached 
124,000 (Lozano et al., 2012). It must be noted, though, that even if the cancer patient 
survives (given that death is not a necessary consequence), the secondary deficits due to 
both the disease itself and the curative efforts can seriously affect oral functions 
(Schuster et al., 2012) and quality of life in turn. Although advanced prosthetics offer 
near optimal restorative solutions (Nagy et al., 2013), the survivor, having undergone 
the disease and its aftermath, still bears an immense psychosocial burden.  
In Hungary, the incidence and mortality of cancers of the lip and oral cavity is the 
highest in Europe, and the incidence of lung, lip and oral cancers together - where 
smoking is the single highest risk factor - is the highest in the world (GLOBOCAN 
2012, WHO).   
Cancers of the lip and oral cavity, however, represent only a segment of the range of 
oral diseases associated with smoking. Population-based epidemiological studies have 
found that periodontitis is more common in smokers than in nonsmokers (Beck et al., 
1990; Tomar et al., 2000), and the association between smoking and tooth loss has also 
been established (Hanioka et al., 2011). The association between tobacco use and acute 
ulcerative gingivitis (ANUG) was demonstrated as early as 1947 (Pindborg 1947). 
Smoking causes deeper periodontal pockets and greater atachment loss (Linden et al., 
1994). The prevalence of furcation involvement is also higher in smokers, than in 
nonsmokers (Mullally et al., 1999), and the fact, that alveolar bone loss is greater in 
smokers has been documented since decades (Bergström et al., 1987).  
Smoking can cause tooth discoloration (Alkhatib et al., 2005), and staining on the 
surface of dental restorations (Asmussen et al., 1986). There is evidence to suggest that 
smoking increases the chance of dental caries (Golpasand et al., 2013; Bendetti et al., 
2013), but this is a matter of debate.  
	   7	  
 
2.3. Links and associations between oral and extraoral diseases: the rationale behind the 
clinical study  
 
 
Several oral conditions are associated with systemic diseases, and it is a well-known 
fact that the oral manifestations of such diseases can often be of diagnostic value.  
For instance, avitaminosis due to malnutrition or metabolic can have severe oral 
consequences, such as stomatitis, cheilitis and glossitis (Field et al., 1995). 
Kwashiorkor, caused by protein deficiency, can lead to the well known noma (Heird et 
al., 2007) and the oral manifestation of amyloidosis can be macrgoglossia (Thibault et 
al., 2011). Plaque on the tongue or oral discolorations can be indicative of 
cardiovascular diseases, but these can also increase the likelihood of and/or aggravate 
periodontal disease. Furthermore, there is evidence to suggest that periodontal 
pathogens can modulate the process of atherosclerosis, thus playing a role in the 
development of coronary disease (Thomopoulos et al., 2011).  
Numerous studies describe the interplay between systemic diseases and oral conditions. 
The most often studied of such conditions is periodontal disease. Periodontal disease is 
a destructive inflammatory disease of the supporting tissues of the teeth and is caused 
by specific microorganisms (Saini et al., 2009). These microorganisms, especially when 
accumulated in dental plaque, maintain a local immune reaction, which gives rise to the 
primary disease in situ. However, these pathogens, including Porphyromonas gingivalis, 
have the ability to invade the endothelium, whereby they easily access the circulation 
(Lundberg et al., 2008; Lu et al., 2009). The ensuing chronic bacteraemia can trigger 
pathological processes at distant sites, such as in the joints and the endocardium 
(Wegner  et al., 2010), which eventually turn into clinical conditions like rheumatoid 
arthritis (Detert  et al., 2010) and endocarditis.  
Several studies demonstrated connection between periodontal disease and a 
considerable number of systemic conditions, and in most of these cases the connection 
cannot be put down simply to lasting bacteraemia. There is evidence to suggest, for 
instance, that moderate periodontal disease occurs more frequently among chronic 
kidney disease (CKD) patients as compared to individuals without the disease 
(Ioannidou et al., 2011).  The same has been demonstrated in patients with diabetes 
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mellitus (Khader et al., 2006), and the effect appears to be the most pronounced in Type 
2 cases (Pranckeviciene et al., 2014). 
In the first part of the present thesis, a study about a similar, if less researched link is 
discussed. Since the first cross-sectional pilot study in 2010 (Preus et al., 2010) that 
raised the issue of the association between psoriasis and chronic destructive periodontal 
disease, surprisingly few studies have examined the claimed link. An  increased risk of 
psoriasis among patients with chronic periodontitis has been detected (Keller  et al., 
2012) and  Lazaridou et al. proposed that chronic plaque psoriasis patients should be 
closely followed-up by dentists for the adequate and early treatment of periodontitis, 
given an increased risk of the latter (Lazaridou et al., 2012).  Evidence published so far 
unequivocally suggests that the two conditions are related. In our clinical study, we 
sought to test if the link does indeed exist (as suggested), but a new aspect was also 
added. As both smoking and psoriasis has been proposed as triggers and/or aggravating 
factors in periodontal disease (Beck et al., 1990; Tomar et al., 2000; Preus et al, 2010; 
Lazaridou et al., 2012), the new research objective was to find out about how smoking 
influences the severity of periodontal disease in the presence of psoriasis, that is, when 
both predisposing factors are present.  
 
2.4.  On the need to introduce tobacco cessation counseling into the dental curriculum 
 
In the European Union, less than 10% of dentists smoke every day, and three quarters of 
all practices are totally smoke free (Allard, 2010), and in the US, some studies have 
reported smoking prevalence as low as 3% among dentists (Brothwell et al., 2004). 
However, in Eastern Europe, the situation is far from being that optimal. In our studies 
regarding this question, we found a decreasing, but still quite high percentage of 
smokers among dentists and dental students. In 2004, 35.5% reported to have smoked at 
least one day in the last month (Nagy et al., 2004), while in 2011, 22.3% of the dentists 
and 20.3% of the dental students defined themselves as smokers (Antal et al., 2012). In 
comparison, a 35% smoking rate was found among Jordanian dentists, and 83% of the 
smoking dentists were daily smokers (Burgan et al., 2003). In Laos, a smoking 
prevalence of 7.9% was reported among dental students (Sychareun ez al., 2013), while 
in Iran, 20.6% of a sample of dental students were found to use tobacco in different 
forms (Keshavarz et al., 2013). These data point out that smoking (and tobacco use in 
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general) among dental students and dentists shows a high geographical variability, and 
that Hungary is among the more affected areas. This means that the tobacco-related 
health-consciousness among Hungarian dental students and dentists is still not at the 
level that could shape their actual behavior. On one hand, this puts students’ and 
dentists’ health at risk, but on the other hand, a smoking dental professional cannot 
serve as a valid and congruent role model for cessation, which means that such 
professionals miss an important chance to support their smoking patients’ health.   
In terms of chances for cessation counselling, dentists seem to be in quite an 
advantageous situation; according to Garvey (Garvey et al., 1997), the expected quit 
rates are comparable with the succes of physicians.  Furthermore, dentists are in a 
special situation, as they may be the first to notice damage caused by regular tobacco 
use, sometimes well before the actual manifestation of any kind of oral disease. Also, 
the dental office is a setting where it is „natural” to talk about oral problems that 
otherwise would possibly embarrass patients (such as bad breath or tooth discoloration). 
All in all, the dental office appears to be just the optimal venue for tobacco intervention 
in many respects, thus a possible and very promising strategy to reduce the prevalence 
of smoking-related oral diseases or even mortality is to increase the involvement of the 
dental team in tobacco prevention and cessation counselling (Walsh et al., 2005). To 
reach that end, the implementation of tobacco use- and cessation-related education for 
dental students and dentists is essential (Warren et al., 2005; Shibly et al., 2010). 
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3. Periodontal disease in psoriasis as determined by smoking: further evidence to 
support the immunomodulatory effect of cigarette smoke 
 
 
3.1. Background and aims 
 
Population-based epidemiological studies have found that periodontal disease is more 
common in smokers than in nonsmokers (Beck et al., 1990; Tomar et al., 2000). Beyond 
the obvious explanation that tobacco smoke is a local irritant, it has been shown that 
smoking favors colonization by specific periodontopathic bacteria (Kubota et al., 2011), 
modulates cellular immunity (Korn et al., 2005; Sopori, 2002; Sulivan et al., 2005) and 
favors the development and aggravation of autoimmune and immune-mediated 
conditions (Masdottir et al., 2000; Mathews et al., 1973), including psoriasis (Emre et 
al., 2012). Smoking, therefore, appears to be a risk factor for both periodontal disease 
and psoriasis. What is more interesting is that psoriasis and periodontal disease seem to 
be associated themselves. It was Yamada and colleagues in 1992 who first reported a 
case of psoriasis in which exacerbation of the cutaneous disease was accompanied by 
gingival epithelial changes and periodontal bursts (Yamada et al., 1992), but the first 
blinded, case-controlled study on the assumed association was published only eighteen 
years later by Preus and colleagues (Preus et al., 2010). This was the first study to 
seriously raise the issue of the possible association between the two conditions, 
followed by the studies of Lazaridou et al. (Lazaridou et al., 2013) and Keller and Lin 
(Keller et al., 2012), both of which corroborated the findings of the Preus group.  
It is established that the immunopathogenesis of psoriasis (Schon et al., 2005) and the 
aggravation of periodontal disease (Ohlrich et al., 2009) is linked to altered T- 
lymphocyte - mediated immunity. Periodontal disease turns progressive when B-
cell/plasma cell responses become dominant in the periodontal inflammatory process, 
which is preceded by the oligoclonal expansion of Th2 lymphocytes. These lymphocytes 
stimulate B-cells and induce humoral immune responses by secreting  interleukins IL-4, 
IL-5 and IL-10 (see Table 1). It is to be noted that Th1 cells are also capable of 
stimulating B cells by secreting INF-γ. This can be an alternative way of shifting the 
immune response toward B cell dominance, especially in the context of suppressed T 
cell responses (as it happens in the oligoclonal expansion of Th2 cells). Th1 cells are 
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stimulated by IL-6, IL-8, IL-12, IL-18, TNF-α and INF-γ, the levels of all of which 
were found to be elevated in the serum of patients with chronic plaque psoriasis (Arican 
et al., 2005).  It might not be too far-fetched to hypothesize that psoriasis can aggravate 
periodontal disease because enhanced Th1 INF-γ secretion furthers the effects of Th2 
dominance. However, the clarification of the molecular level basis of the link between 
the two conditions was no subject of this study. 
As tobacco smoking also interferes with immunity, favors colonization by 
periodontopathic bacteria and acts as a local irritant, we hypothesized that smoking may 
act as a trigger or permissive factor of periodontal disease in patients suffering from 
psoriasis. To test this hypothesis, the prevalence and severity of periodontal disease was 
assessed in a group smoking and non-smoking psoriasis patients and a group of 
smoking and non-smoking psoriasis-free controls. The specific question we sought an 
answer to was whether periodontal disease occurs more often and in a more serious 
form in smoking psoriasis patients than in non-smoking psoriasis patients. The primary 
aim of the study, therefore, was to find evidence for or against the hypothesized 
permissive role of smoking. 
 
3.2. Methods 
 
Data for the study were gathered in two stages: first, participants were administered a 
questionnaire (non-clinical stage), and then they underwent a full intraoral examination 
(clinical stage).  
3.2.1. Participants and non-clinical data gathering 
A hospital-based case-control study was conducted in 2012. Participants (n=82) were 
selected from the patients of the Psoriasis Outpatient Unit of the Department of 
Dermatology and Allergology, University of Szeged. The control group (n=89) was 
recruited from people attending mandatory lung screening in the same city and the same 
period, on a voluntary basis. Controls were age-matched to patients, but the sex ratios 
were also almost identical (see Table 2.). Required sample size was calculated with 
G*Power 3.1.5. (University of Kiel, Germany), a software designed especially for 
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statistical power and sample size computation (Faul et al., 2007). The software allows 
the computation of achieved statistical power (post-hoc) and required sample size (a 
priori). As mostly categorical variables were to be analyzed, a priori sample size 
estimation was performed for crosstabs/chi square/contingency tables, with the 
following input parameters:  effect size (w): 0.5; α: 0.05;power (1-β): 0.85; DF: 3. 
Required sample size turned out to be n=50, but much more cases were available, 
whereby, also expecting dropout,  it was decided that 100 cases and 100 controls would 
be examined. This way, even with the dropout of 18 cases and 11 controls, a statistical 
power over 0.9 was achieved. 
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CLINICAL	  STAGING	   PATHOLOGY/PATHOPHYSIOLOGY	  
(Fernandes	  et	  al.,	  2009)	   (Ohlrich	  et	  al.,	  2009)	  
	   	  
1.NO	  CLINICAL	  SIGNS-­‐	  no	  clinical	  attachment	  loss	  (CAL)	  or	  bleeding	  on	  probing	  (BOP)	  	   (NO	  LESION-­‐	  NOT	  CLASSIFIED	  EXPLICITLY	  IN	  OHLRICH	  ET	  AL.)	  
	   	  (GINGIVITIS-­‐NOT	  CLASSIFIED	  EXPLICITLY	  IN	  FERNANDES	  ET	  AL.)	  	   1.	  INITIAL	  LESION	  –	  up	  to	  4	  days	  following	  plaque	  accumulation.	  Polymorphonuclear	  leukocytes	  (PMN),	  complement	  activation,	  loss	  of	  connective	  tissue.	  Mast	  cells	  release	  tumor	  necrosis	  factor	  alpha,	  PMNs	  migrate	  into	  the	  gingival	  sulcus,	  but	  as	  the	  bacteria	  are	  protected	  by	  the	  biofilm,	  abortive	  phagocytosis	  occurs.	  PMNs	  release	  lysosomal	  contents,	  which	  leads	  to	  further	  tissue	  destruction.	  
(CPITN	  1)	  
	   	  
2.EARLY	  PERIODONTITIS-­‐	  CAL	   2.EARLY/STABLE	  LESION-­‐	  	  7-­‐21	  days	  after	  plaque	  accumulation,	  clinically	  evident	  approximately	  from	  day	  12.	  Dominantly	  macrophages	  and	  lymphocytes	  (CD4+:CD8+	  2:1).	  Perivascular	  inflammatory	  infiltrate.	  Intercellular	  spaces	  between	  epithelial	  cells	  widen,	  bacterial	  products	  infiltrate	  the	  gingival	  tissues	  at	  a	  higher	  rate.	  Escalation	  of	  response.	  If	  plaque	  removed,	  tissue	  remodeling	  can	  take	  place.	  	  	  
≥1	  mm	  in	  ≥2	  teeth	  	  (CPITN	  2)	  
	   	  
3.MODERATE	  PERIODONTITIS-­‐	  3	  sites	  with	  CAL	  ≥4	  mm	  and	  at	  least	  2	  sites	  with	  probing	  depth	  (PD)	  ≥3	  mm	  	  
3.	  ESTABLISHED	  OR	  PROGRESSIVE	  LESION-­‐	  dominantly	  a	  B	  cell/plasma	  cell	  response.	  High	  levels	  of	  IL-­‐1	  and	  IL-­‐6:	  connective	  tissue	  loss,	  breakdown	  of	  bone.	  (CPITN	  3)	  
	   	  
4.	  SEVERE	  PERIODONTITIS-­‐	  CAL	  ≥6	  mm	  in	  ≥2	  teeth	  and	  PD	  ≥5	  mm	  in	  ≥1	  site	  	   4.	  ADVANCED	  LESION-­‐	  Overt	  loss	  of	  attachment.	  High	  levels	  of	  IL-­‐1,	  TNF	  α	  and	  PGE2	  stimulate	  fibroblasts	  and	  macrophages	  to	  produce	  matrix	  metalloproteases.	  The	  junctional	  epithelium	  progresses	  in	  apical	  direction	  (deepening	  periodontal	  pocket).	  Oligoclonal	  Th2	  (CD4+)	  dominance.	  	  	  
(CPITN	  4)	  
	   	  
Table 1. The applied clinical staging and the corresponding pathological/pathophysiological 
changes. The approximate CPITN stage is also given (in brackets).  
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   PSORIASIS	   	   CONTROL	  
	   	   	   	  
Age	  (mean±SD,	  years)	   50.9±13.4	   	   50.3±13.7	  
smoker	  subsample	   48.5±14.0	   	   43.3±12.4	  
nonsmoker	  subsample	   54.7±12.9	   	   52.9±14.7	  
	   	   	   	  
Sex	  ratio	  F:M	  (n(%):n(%))	   45(55%):37(45%)	   	   44(49%):45(51%)	  
smoker	  subsample	   24(60%):21(40%)	   	   12(50%):12(50%)	  
nonsmoker	  subsample	   23(49%):24(51%)	   	   33(51%):32(49%)	  
	   	   	   	  
Smoking	  (n(%))	   35(43%)	   	   24(27%)	  
	   	   	   	  
Periodontal	  status	  in	  smokers	  
(n)	  
healthy:	  	  -­‐	   reference	  category	   healthy:	  10	  
	   early:	  5	   p<0.001	   early:	  8	  
	   moderate:	  13	   p<0.001	   moderate:	  4	  
	   severe:	  17	   n.s.	   severe:	  2	  
	   	   	   	  
Periodontal	  status	  in	  	   healthy:	  10	   reference	  category	   healthy:	  25	  
nonsmokers	  (n)	   early:	  13	   n.s.	   early:	  19	  
	   moderate:	  18	   p=0.05	   moderate:	  17	  
	   severe:	  6	   p<0.05	   severe:	  4	  
	   	   	   	  	  
Table 2. Descriptive statistics of the study and control groups with the characteristics of the 
subsamples. To keep the table transparent, percentages have been rounded to whole numbers. 
Note that no periodontally healthy smoker psoriasis patients were found. A trend analysis (χ2 
with adjusted residuals) revealed a significant trend (χ2 =48.074, p=0.000), with non-smoker 
controls being the less likely to have any stage of periodontal disease and smoker patients being 
the most likely to have the severe stage.  Significance values refer to the comparison of odds 
with healthy as the reference category (see also Table 3.).  
     
Patients were eligible for the study if they were diagnosed with psoriasis (defined as 
ICD-10 L40.0-L40.9) by a dermatologist. The diagnosis of psoriasis was set up earlier 
than the beginning of this study in all cases, whereby dermatological examination was 
not regarded as a direct part of this study, neither was it listed on the informed consent 
forms as such. Exclusion criteria for both groups were determined based on the 
literature of the subject and included obesity (BMI≥30), excessive alcohol consumption, 
drug abuse, diabetes mellitus, oestrogen deficiency, diseases causing neutropenia and 
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local or systemic inflammatory conditions (other than psoriasis) (Genco, 1996; Genco et 
al., 2013). Dropout resulted partially from meeting one or more of the exclusion criteria 
(especially excessive self-reported alcohol consumption), but there were subjects who 
quit by their own will before the intraoral examination, and a number of subjects failed 
to provide tobacco use data.  
Demographic and tobacco use data were collected by a questionnaire. Medical 
information on both controls and psoriasis patients was extracted from patient files and 
hospital records. Participants were divided into smoker and non-smoker groups, based 
on their self-reported current tobacco use. To minimize desirable response tendency in 
this crucial aspect, smoking was not pointed out to the participants as the target variable 
until all study procedures had been finished.    
The study was approved by the Human Ethics Review Board of the University of 
Szeged (approval Nos. 2848 and 2879), and the study design conformed to the 
Declaration of Helsinki in all respects. Written informed consent was obtained from all 
participants.  
3.2.2. Disease staging and intraoral examination  
The clinical staging of periodontal disease is still a matter of debate, even though the 
progression of the disease is well established in pathological terms (Ohlrich et al., 
2009). The most widely used classification is the Community Periodontal Index of the 
WHO (CPITN) (Barmes, 1994). Applicable as it may be for clinical purposes, CPITN 
defines rather wide categories, which carries the risk of oversampling. Therefore we 
decided to use the more detailed (and thus more strict) staging proposed by Fernandes 
and colleagues (Fernandes et al., 2009). The staging requires the following parameters 
to be recorded: the number of missing teeth (excluding third molars), Plaque Index (PI; 
also known as the Silness-Löe Index), bleeding on probing (BOP; the presence or 
absence of bleeding within 15 sec after probing), probing depth (PD; in millimeters), 
and clinical attachment level (CAL; to describe the position of the soft tissue in relation 
to the cemento-enamel junction ).  
In order to record the above mentioned parameters, all patients received a full mouth 
periodontal examination, performed by a periodontist. BOP, PD and CAL were 
examined six sites per tooth (mesio-buccal, buccal, disto-buccal, disto-lingual, lingual, 
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mesio-lingual), with the exception of third molars. Williams probes (Hu-Friedy 
Manufacturing Co., Chicago, USA) were used. Table 1 shows the categories of the 
applied staging and the corresponding pathological/pathophysiological status.  
 
3.2.3. Statistical Analysis 
The study and control groups were compared by smoking status. To express the 
probability that a member of a given group develops a given clinical degree of 
periodontal disease, multinomial logistic regression was conducted and the odds ratios 
were calculated. In the multinomial model, disease severity (healthy, early, moderate, 
severe) was defined as the outcome variable, smoking status (smoker or non-smoker), 
and group (psoriasis or control) were defined as factors, and smoking intensity 
(expressed as the number of cigarettes smoked per day) was defined as a covariate. 
Descriptive statistics and odds ratios were calculated in SPSS 17.0 (SPSS, Inc., 
Chicago, USA).   
3.3. Results 
3.3.1. The population 
Table 2. shows the descriptive statistics of both the study and the control groups. 
Females were slightly over-represented in the psoriasis group (nfemale=45, nmale=37) 
while in the control group the sexes were represented almost perfectly equally 
(nfemale=44, nmale=45). Crosstab analysis with χ2 test was conducted to find out if sex 
was significantly associated with disease severity, but the association turned out to be 
non-significant for both patients (χ2 =5.184 p= 0.189) and controls (χ2 = 3.029, 
p=0.387), whereby sex was not included in the multinomial regression.  Patients and 
controls were age-matched (mean age for the entire sample: 50.6 years). The division 
into four groups by diagnosis (psoriasis or control) and smoking status (yes or no) for 
the purposes of the analysis did not change these parameters significantly, that is, the 
ratios remained representative of the whole sample. Group membership (i.e. patient or 
control)  was shown to be significantly associated with disease severity (χ2= 27.337, 
p=0.000).   
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In the psoriasis group 35 persons defined themselves as smoker (43%). The number of 
smokers was lower among the control group, only 24 persons defined themselves as 
smoker (27%).  In the psoriasis+smoker group no patient could be categorized as 
periodontally healthy.  14% of this group had early, 37% moderate and 49% severe 
periodontal disease.  Among non-smoker patients 21% were classified as healthy, 28% 
as having early, 39% as having moderate and 12% as having severe periodontal disease. 
42% of smoking controls was periodontally healthy, 33% had early, 17% moderate and 
8% severe periodontal disease. Nonsmoking controls were periodontally healthy in 
38%, 29% had early periodontal disease, while in 26% of the cases the disease 
presented in its moderate and in 7% in its severe form. These data reflect opposing 
tendencies between smoker patients and non-smoker controls, that is, while in the 
smoker patient subsample the severe stage of periodontal disease is the most frequent, 
and no periodontally healthy patient is seen, in the non-smoker control subsample 
exactly the opposite can be observed (Figure 1.).   
	  	  
Figure 1. Opposing tendencies: while in the smoker patient subsample the severe stage of 
periodontal disease was the most frequent, and no periodontally healthy patient was seen, in the 
non-smoker control subsample exactly the opposite was observed.  
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3.3.2. Smoking history and smoking intensity 
In terms of smoking history (expressed in years) and their intensity of smoking 
(expressed as the number of cigarettes smoked per day), controls and psoriasis patients 
turned out to be quite similar. Smoking controls had smoked for a mean of 20.9 years 
(mode: 20 years, SD: 11.97), and they smoked a mean of 16 cigarettes a day (mode: 20 
cigarettes, SD: 11.67). Smoking patients had smoked for an average of 16.57 years 
(mode: 20 years, SD: 12.37), and they smoked an average of 13 cigarettes a day (mode: 
20 cigarettes, SD: 8.57). Indeed, the two groups exhibited no statistically significant 
difference in either of these parameters (MWU=315, n1=35, n2=24, p=0.17, years; 
MWU=758, n1=35, n2=24, p=0.57, cigarettes). The crosstab analysis revealed that 
smoking status in itself was significantly associated with disease severity only in 
patients (χ2= 18.258, p=0.000). In controls, no significant association was seen (χ2= 
0.935, p=0.812). However, when the data were re-coded so that the outcome variable 
was not disease severity, but the occurrence of any stage of the disease, the association 
was highly significant (χ2= 89.000, p=0.000).  As for smoking history and intensity, the 
built-in likelihood ratio test of the multinomial logistic regression module of SPSS 
revealed that smoking history had a significant effect on disease severity (χ2 = 11.099, 
p=0.011), but the effect of smoking intensity was not significant (χ2= 30.862, p=0.504). 
 
3.3.3. Odds Ratios 
Odds ratios with significance and confidence intervals are given in Table 3. Odds ratios 
were calculated in a multinomial logistic regression model. Smokers and controls were 
compared stagewise, according to the applied classification. The factors of the model 
were smoking status (smoker or non-smoker) and group (patient or control), and the 
covariate was smoking history (in years). Five comparisons were done, that is, non-
smoker controls were compared with smoker controls (OREARLY: 1.053 , ORMODERATE: 
0.588, ORSEVERE: 1.250 ), with non-smoker patients (OREARLY: 1.944 , ORMODERATE: 2.647, 
ORSEVERE: 4.373 ) and with smoker patients (OREARLY: 1.711 , ORMODERATE: 2.500, 
ORSEVERE: 24.278), smoker patients were also compared with non-smoker patients 
(OREARLY: 6.082 , ORMODERATE: 1.712, ORSEVERE: 4.480 ), and smoker controls were 
compared with smoker patients (OREARLY: 1.904 , ORMODERATE: 9.900, ORSEVERE: 2.589 ).  
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Significantly higher odds of developing moderate (p=0.05) and severe (p<0.05) 
periodontal disease were found when non-smoker patients were compared against non-
smoker controls (the periodontal risk of psoriasis alone). The highest odds ratio resulted 
from the comparison of smoker patients with non-smoker controls (24.278, p<0.001), 
which is 4.43 times higher than the combination of the individual odds of smoking 
(1.250, n.s.) and psoriasis (4.373, p<0.05). It must be noted, though, that the high odds 
ratio had a rather wide confidence interval. When compared with non-smoker patients, 
smoker patients’ odds of developing periodontal disease was significantly higher at all 
three stages (p<0.001). Finally, as compared to smoker controls, smoker patients’ odds 
of developing early or moderate periodontal disease were also significantly higher 
(p<0.001), but no significant difference was observed regarding the severe stage of the 
disease.  
The covariate smoking history was significantly associated with disease severity in both 
patients (χ2 = 12.204, p=0.014) and controls (χ2 = 9.869, p=0.02). The odds ratios were 
positive for the moderate and severe stages in both groups (ORCONTROL, MODERATE: 1.145, 
CI:0.999-1.312; ORCONTROL, SEVERE: 1.164, CI: 0.963-1.408; ORPATIENT, MODERATE: 1,112, CI: 
0.939-1.318; ORPATIENT, SEVERE:1.185, CI: 0.998-1.406), indicating that a longer smoking 
history significantly increases the odds that the moderate or severe stage of the disease 
occurs, as compared to the early stage.   
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COMPARISON STAGE OR Sig. 95% CI (lower ;upper) 
     
SMOKER 
CONTROLS 
(vs. non-smoker 
controls) 
early 1.053 n.s. 0.394;3.177 
moderate 0.588 n.s 0.158;2.187 
severe 1.250 n.s 0.197;7.942 
NON-SMOKER 
PATIENTS (vs. 
non-smoker 
controls) 
early 1.944 n.s. 0.706;5.353 
moderate 2.647 p=0.05 0.985;7.113 
severe 4.373 p<0.05 1.114;17.169 
SMOKER 
PATIENTS (vs. 
non-smoker 
controls) 
early 1.711 n.s 0.618;4.732 
moderate 2.500 n.s 0.924;6.761 
severe 24.278 p<0.001 5.207;113.189 
SMOKER 
PATIENTS (vs. 
non-smoker 
patients) 
early 6.082 p<0.001 1.516;2.440 
moderate 1.722 p<0.001 3.535;3.689 
severe 4.480 p<0.001 1.651-6.851 
SMOKER 
PATIENTS (vs. 
smoker controls) 
early 1.904 p<0.001 1.202; 3.016 
moderate 9.900 p<0.001 1.568;6.262 
severe 2.589 n.s. 2.108;2.695 	  
Table 3. Odds ratios by clinical staging. In each case, the ratios express the odds that a member 
of the given category (printed in capitals) develops the given stage of periodontitis in 
comparison with the members of another category (in brackets). Significance levels and 95% 
confidence intervals (with lower and upper limits) are also given.  
 
3.4. Discussion 
In the present study it was demonstrated that psoriasis patients who smoke are at an 
approximately sixfold higher risk of developing severe periodontal disease, as 
compared to psoriasis patients who do not smoke. Psoriasis in itself increases the 
likelihood of severe periodontal disease to 4.373 (as compared to non-smoker controls), 
while smoking appears to increase this to 24.278. In other words, the risk of severe 
periodontal disease in psoriasis is approximately six times higher in smokers than in 
non-smokers. It would be reasonable to infer that this increase in risk is merely the 
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result of the individual risk factors adding up. To test that possibility, odds ratios were 
combined and the synergy factor was calculated.     
Combined odds expresses the probability of a given condition if all combined risk 
factors are present. For samples of similar size, combination of odds is done by 
averaging their logs (logOR1/logOR2). For psoriasis alone (4.373) and smoking alone 
(1.250), the combined odds of severe periodontal disease is 6.60, far below the observed 
24.278. From this it may be conferred that what is observed in smoker patients is not 
simply the odds of psoriasis and smoking added up. Computation of the synergy factor 
corroborates this suspicion. The synergy factor was devised by Cortina-Borja and co-
workers (Cortina-Borja et al., 2009) to allow the estimation of whether two factors are 
in a positive or negative interaction in terms of bringing about a given condition, based 
on their individual odds. The factor is calculated as SF =OR12/(OR1 × OR2), where OR12 
expresses the combined odds of the examined factors. SF=1 expresses the simple 
addition of the odds, SF<1 means negative interaction (antagonism)  and SF>1 denotes 
positive interaction (synergy). The value of the synergy factor for the odds of psoriasis 
and smoking is 1.2, indicating a synergistic effect. It seems, therefore, that smoking acts 
as a permissive factor.  
It was also found that the association between smoking status and disease severity is 
significant only in the patient group, which is also to support that exposure to cigarette 
smoke and psoriasis act together toward the aggravation of periodontal disease. The 
lack of significant association, however, should not be interpreted as evidence that 
cigarette smoke alone does not cause periodontal disease. Evidence suggests that it does 
(Tonetti 1998), and the additional analysis also showed that when the target variable is 
the occurrence of periodontal disease, the association is highly significant. From this it 
might be inferred, that smoking increases the odds of periodontal disease in both 
controls and psoriasis patients, but psoriasis patients are perdisposed to the more severe 
forms of the disease.  
A further interesting result is the significant association of smoking history with the 
occurrence of the moderate and severe forms of periodontal disease in both groups. 
Together with the lack of significant association with the number of cigarettes smoked 
per day, it suggests that the key factor in the proposed permissive role of cigarette 
smoke is chronic exposure, apparently regardless of how heavy a smoker one is.        
As no study before has dealt with the effects of smoking on periodontal disease severity 
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in psoriasis, it is beyond our limitations to give an exact explanation of these findings. 
However, enough is known about the pathogenesis of psoriasis and periodontal disease 
and the pathophysiological effects of smoking to allow the articulation of the elements 
of a hypothesis, which we briefly delineate here.  
As pointed out by Ohlrich and co-workers, the most readily observable difference 
between the early and later stages of periodontal disease is that in the later stages the 
inflammatory response is dominated by B lymphocytes, instead of T lymphocytes 
(Ohlrich et al., 2009). It is in the context of this exaggerated and maladaptive B 
cell/plasma cell response that periodontal tissue destruction and bone breakdown 
occurs. Our propsed hypothesis, therefore, centers around this T-to-B shift, which 
appears to be the key event in the aggravation of periodontal disease, and how cigarette 
smoke might play a permissive role in the process. Here we concentrate only on a 
putative immunological backrgound, while we understand that additional factors, like 
the detrimental effect of smoking on gingival circulation (Mavropoulos et al., 2007) can 
also contribute to the end result.   
It is well established that psoriasis is associated with a millieu of inflammatory 
mediators that favors a shift toward B cell responses. Serum levels of the inflammatory 
mediators IL-6, IL-8, IL-12, IL-18, TNF-α and INF-γ were found to be elevated in 
plaque psoriasis [17]. These mediators are all documented to activate B cells (Hirano et 
al., 1986; Falkoff et al., 1983; Durali el at., 2003; Rieckmann et al., 1991). TNF-α is 
also a potent stimulant of fibroblasts and macrophages, which, upon activation, release 
matrix metalloproteases (Ohlrich et al., 2009). As mentioned before, periodontal disease 
itself is associated with Th2 expansion.  This, on one hand, suppresses T cell responses, 
but Th2 cells, in the presence of antigen, can stimulate B cells too (Del Prete, 1998).  
Therefore, it might be argued that psoriasis increases susecptibility to destructive 
immune responses in general by shifting the immune response profile toward B cell 
responses, which would explain the original observation - also corroborated by this 
study-  that patients with psoriasis develop periodontal disease more often than 
psoriasis-free individuals.  
How, then, might cigarette smoke boost this effect? We propose that toll-like receptor 4 
(TLR 4) can play a key role here. Toll-like receptors are preferentially expressed on 
immune cells, and mediate immune responses. TLR4 on the surface of Th1 cells 
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activate these cells upon binding to bacterial lipopolysaccharides to secrete INF-γ , a 
potent B cell activator (Netea et al., 2005). Normally, this is part of the immune 
response to bacterial colonization of the gingival sulcus. However, if TLR 4 is 
overexpressed, the response may become exaggerated and maladaptive. Pace and co-
workers demonstrated that cigarette smoke causes upregulation of TLR4 in airway 
epithelial cells of smokers with COPD, and they proposed that this upregulation might 
be the reason why a dominantly Th1-regulated immune response is seen in the airways 
of COPD patients (Pace et al., 2008). The authors also demonstrated that cigarette 
smoke increased epithelial cells’ ability to bind bacterial lipopolysaccharides (Pace et 
al., 2008). TLR4 upregulation was demonstrated in the psoriatic skin too (Curry et al., 
2003). It is not known if cigarette smoke has the same effect in the periodontal tissues 
(and on the surface of Th1 cells), but it seems plausible to assume that TLR 4 
upregulation can be the key step in the destructive T- to B- shift in periodontal disease 
in the context of an already B-biased inflammatory mediator environment. Based on the 
literature, it can be proposed that the examination of the effects of cigarette smoke on 
TLR4 expression in the gingival tissues could be a logical next step toward the 
understanding of our observations, which we are planning to undertake. 
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4. Introducing tobacco cessation counseling into the dental curriculum 
 
Considering that, as mentioned under 2.2. and 2.4., Hungary is a leading country in 
terms of tobacco-related morbidity and mortality, with a notable percentage of smokers 
among dental students and dentists, and that the dental office could be a distinguished 
venue of tobacco use interventions if well-prepared professionals were available who 
could also serve as a role model, we decided to introduce a new element into the 
curriculum of the Faculty of Dentistry at the University of Szeged. This new curricular 
element was intended to provide dental students both theoretical and practical training 
in cessation counseling, so as to enable them to offer such counseling and also to 
increase their tobacco-related health-consciousness. The second part of the thesis 
describes the methodology of this new curricular element, and also discusses the initial 
experiences.   
  
4.1.  Cessation support by oral health professionals 
 
The importance of cessation support interventions done by oral health professionals is 
getting widely recognized. The dental practice setting has been described as providing a 
unique opportunity to assist tobacco users in achieving abstinence or even quitting 
tobacco (Christen et al., 1990; Ramseier et al., 2010; Needleman et al., 2010). More 
specifically, evidence suggests that behavioral interventions for tobacco cessation 
conducted in the dental office and involving an oral examination component may 
increase the quit rates among cigarette smokers (Carr et al., 2012). It is true that quit 
rates are similar to those achieved by physicians and other healthcare providers 
(Warnakulasuriya 2002), but oral health professionals recognize patient tobacco use 
more readily (Block et al., 1999). Furthermore, dentists are in a special situation, as they 
may be the first to detect damage caused by regular tobacco use, sometimes well before 
the actual manifestation of any kind of oral disease. Thus, a possible and very promising 
strategy to reduce the prevalence of smoking- related oral diseases or even mortality is 
to increase the involvement of the dental team in tobacco prevention and cessation 
counseling (Walsh et al., 2005). 
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Several tobacco cessation support methodologies are known, from brief advice and 
quitline referral (Ebbert et al., 2007) to video-based cessation support with phone 
follow-up (Andrews et al., 1999; Severson et al., 2009).  Motivational Interviewing 
(MI) is often part of these approaches (Lando et al., 2007). MI is a patient-oriented 
method aimed at increasing the patients’ inner motivation to change their behavior by 
exploring and resolving ambivalence (Miller et al., 2002). As dentists have only a 
limited timeframe at their disposal for cessation support, it has been proposed that the 
shorter, questionnaire-based form of MI, better known as "Brief Motivational 
Interviewing" (BMI) should be used in the dental practice (Rollnick et al., 1997).  If 
BMI is used in the framework of the 5As approach (ask, advise, assess, assist, arrange 
follow-up) (Needleman et al., 2010) and pharmacological augmentation is also applied 
(such as nicotine replacement therapy), quit rates up to 15% can be achieved in a three-
month period, compared to the 9% seen with other cessation support approaches  
(Binnie et al., 2007). 
 
4.2. Smoking prevention in the dental practice: a new course in the curriculum 
 
With all the information available in the literature and our experience of dentist-patient 
communication in mind, we proposed a new course titled „Smoking prevention in the 
dental practice” in the period 2008-2009. The course proposal was accepted by the 
Education Committee of the dental school in November 2009, and the first course 
started in February 2010, the spring semester of the academic year 2009-2010. The 
Semmelweis University in Budapest followed suit in 2011. In brief, the course consists 
of a sixty-minute-long theoretical class per week and four practice sessions. During the 
practice sessions students have the chance to practice various dentist-patient 
communication situations with professional actors. These encounters are recorded and 
the video is analyzed.  So far 70 students have finished the course.  
 
4.2.1. Aims of the course 
 
The ultimate aim of the course is that dental students be able to help patients with 
behavioral and pharmaceutical cessation techniques. A further -similarly important- 
goal is to provide students the theoretical basis and practical skills that will make them 
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congruent role models for cessation. Throughout the course, three tenets are 
emphasized, so that students can appreciate the importance of cessation support as a 
dentist’s task: the first is that although 75%-85% of smokers want to quit smoking 
(Garvey et al., 1997), only a small percentage can succeed without professional help. 
Second, that approximately 17% of smokers are ready to give up smoking within the 
next six months at any given time (Walsh et al., 2005). Third, that the relationship 
between the dentist and the patient opens up a platform for personal guidance and 
consultation. This increases the probability of successful cessation (Warren et al., 
2008). The message behind these three tenets is that there is a real need for support, 
there is readiness to accept it, and that the position of a dentist is especially suitable for 
efficient support. A more general aim of the course as a whole is to sensitize 
participants to the problem of smoking-related diseases and the importance of smoking 
prevention and smoke-free life.  
 
4.2.2. The team 
 
The educational team of this program is a multidisciplinary one, which involves a 
professor of dental sciences, two dentists, a specialist of preventive medicine, a general 
practicioner, a communication specialist, and four specially trained professional actors.  
 
4.2.3. Course structure 
 
The course has been designed in a problem-based learning (PBL) framework, which, 
particularly over the past two decades, has become increasingly common in dental 
education (Shibly, 2010; Davis et al., 2010). It comprises three main, consecutive 
phases, as described below (see Table 4. for an item-wise course description).  
The first phase is a theoretical preparation phase. In this first phase students acquire a 
substantial amount of background knowledge on various aspects of nicotine addiction in 
physiological and pathophysiological terms, and about psychological tobacco 
dependence as well. This phase of the course follows the lines laid out by Ramseier et 
al. (Humair et al., 2003).  Several topics of the theoretical sessions are covered by guest 
lecturers, so that students have the chance to learn directly from professionals of the 
different fields involved.  
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Topic Allocated time Course phase 
The epidemiology of 
smoking 
2  hours TP 
National and international 
epidemiology, with special 
emphasis on oral diseases 
2 hours TP 
The chemistry of cigarette 
smoke. The 
pathophysiology of 
smoking. 
2 hours TP 
The behavioral 
background of smoking 
2 hours TP 
Smoking as addiction 1 hour TP 
Risk groups 1 hour TP 
Behavioral modification 1 hour PP 
Clinical interventions and 
preventing relapse 
1 hour PP 
Options for assisting 
tobacco cessation. 
Pharmacologically and/or 
psychologically supported 
cessation. 
4 hours PP 
BMI/5As 2 hours PP 
Individual consultation 1 hour IP 
Consultation on the phone 1 hour IP 
Video simulation 4 hours IP 
Course evaluation 1 hour - 
 
Table 4. Course structure. TP: theoretical preparatory phase; PP: practical preparatory phase; 
IP: interventional practice   
 
The second phase comprises practical preparation.  In this phase, students practice skills 
on each other after that they are trained how to use practical interventional techniques, 
most importantly the technique of MI and BMI. As the efficacy of MI and BMI in 
connection with dependent behavior is supported by several studies (Logan et al., 1999; 
Andersen, 2007; Benowitz, 2008; Rollnick et al., 1999), we put emphasis on its 
knowledge, both in theory and practice. Students learn that the most important aspects 
they have to assess are patients’ readiness to change (Cornuz et al., 2002), how 
important that change for the patient is (Rollnick et al., 1997), and how much the patient 
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is convinced that the change can actually be made (Koerber et al., 2003). Students are 
familiarized with the evaluation of the BMI questionnaires, and they are also taught the 
patient guidance styles to be used with BMI (Fiore et al., 2008).  
Students also obtain information about evidence-based methods for tobacco use 
cessation, including the well-established 5As Method (WHO, 2012) and its combination 
with pharmacotherapeutic solutions.   
In the practical part of this phase, students get a written manual, which describes the 
BMI protocol step-by-step, summarizes the 5As Method, and contains scenario scripts, 
which describe the ways, concepts and methods of tobacco cessation support. With the 
help of this manual, students have the chance to practice their newly acquired skills in 
pairs, based on made-up situations  
In the third, intervention practice phase, students participate in an interactive, 
videofeedback-supported communication training, which is the real methodological 
novelty of this approach. To our knowledge, our Faculty has been the first to integrate a 
videofeedback- and simulation-based undergraduate tobacco cessation counseling 
course into a university curriculum worldwide.  
With the help of professional actors real-life dental encounters are simulated, these 
encounters are recorded and then evaluated together with the actor, students and 
teachers. The simulated situations are complex ones, based on expert experience. The 
situations center around three basic patient attitudes: seeking help with cessation, 
hesitation, and refusal (see Table 5 for an example). 
Both verbal and nonverbal skills are evaluated, so that students are able to learn about 
and gain a deeper understanding of the particularities of communication in clinical 
situations through direct involvement. Written feedback (in the form of an evaluation 
sheet) is given by both a teacher and the actor playing the patient. Points to be evaluated 
by the teacher include various aspects of verbal and nonverbal communication, history 
taking, and the ability to getting medical information through, while the patient sheet 
gives an opportunity to aspects like friendliness, openness toward the psychological 
concerns of the patient or conversational style. Both the teacher and the actor rate each 
particular aspect from 0 to 2 (See Table 6. for a selection of items and evaluation).  
Students’ videos are also discussed in a group training session, where expert feedback 
on desirable communicative elements and ones to be avoided is provided. 
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Situation # 3.: The patient who refuses to quit 
 
Description: It is the patient’s first appointment.  He is a typical hedonist who considers harmful habits as part of 
enjoying life, so much so that these almost seem to be part of his identity. Several years of drinking and smoking 
have done persistent harm to his oral cavity, which is aggravated by poor oral hygiene. His teeth are discolored 
and loose, his gums are atrophic. He seeks help with these problems, however, quitting smoking is the last thing 
he wants to hear about, what is more, he seems to take even the mention of it as an offence. 
Dental status: gingival atrophy, plaques and severe calculus formation. 
Educational goal: To learn how tho approach such patients, how to gain their confidence, and how to make them 
understand that they share a goal with the dentist, which is reaching a solution to their own problem. This should 
be done by establishing a positive tone and guiding the patient toward the realization that the majority of their 
problems stem from smoking, rather than directly telling them so. It should be made clear that the dentist accepts 
the patient’s present decision, but at the same time cessation help should be offered in case the patient changed 
their mind. Agressive reactions are best left without any response, and in no way should they result in counter-
agression. At the end of the appointment the patient should possibly get an appointment card for the next 
appointment, on which the accessibilities of the nearest cessation center are given.  
 
 
Table 5.: An example of the scenarios for the video-feedback practice.  
 
Aspect Evaluation 
Nonverbal communication  
Communicates with facial expressions 0 1 2 
Verbal communication  
Introduces himself/herself 0 1 2 
History taking    
Asks questions regarding the patient’s 
environment 
0 1 2 
Diagnosis    
Succeeds in making the patient 
understand the essence of the 
diagnosis/problem 
0 1 2 
Providing information    
The patient has got involved in 
therapeutic decisions to a satisfactory 
extent 
0 1 2 
Rapport    
Managed to establish a good rapport 0 1 2 
 
Table 6.  Items from teachers’ video evaluation sheet. The main aspects/categories are 
printed in bold. For each category only one item is given here as an example. Evaluation: 0- 
failed to do so; 1- partially succeeded in doing so; 2- carried it out in a satisfactory manner.  
The students who have finished the course are working with real patients now, which 
means an excellent opportunity for efficacy- and progress assessment. For that reason, 
evaluation sheets from the first two semesters of the course have been saved, and now 
patients treated by former course attendees are asked to do the same evaluation. This 
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way it will be possible to tell if the students can apply the knowledge and skills acquired 
in the course with real situations as well, and progress assessment at the individual level 
will be possible as well.  
 
4.2.4. Evaluation of the course- student feedback 
 
As this course has not been part of the curriculum for long, it would be difficult to 
evaluate it in terms of actual cessation support efficacy. Therefore, we concentrate on 
student feedback, which is an important measure of how effective the course may be 
and how well it fits into the curriculum. Obviously, if students find a course useful, 
interesting and well-constructed, the efficacy of that course in terms of knowledge 
transfer increases. Furthermore, such a course is likely to generate more interest among 
future students as well.     
Here we present the results of the student evaluation of our latest course. A short 
questionnaire about the course and its methodology was administered to attendees. 
Altogether 40 questionnaires were completed.  Students were also asked to give a 
descriptive evaluation. The questionnaire was approved by the Institutional Review 
Board at the University of Szeged. 
Three questions were asked. The first one addressed general satisfaction with the course 
(Did the course fulfill your expectations?), the second one asked participants to evaluate 
the theoretical part (Please evaluate the theoretical education during the course.), while 
the third one sought to assess satisfaction with the videofeedback part (Please evaluate 
the videofeedback session.). Participants were instructed to rate these aspects on a five-
level Likert scale, where 1 meant poor, 2 meant below average, 3 meant average, 4 
meant good and 5 meant excellent. Results are presented in Figure 2. To summarize the 
results, more than 90 (n>36) percent of the respondents rated all aspects as excellent or 
good, which signifies a high level of satisfaction. Only five percent (n=2) indicated 
average general satisfaction and two and a half percent (n=1) rated the course in general 
as poor. Neither the theoretical nor the videofeedback sessions were rated lower than 
average. Satisfaction with the videofeedback sessions was remarkable: 77.5 percent 
rated them as excellent.  
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Figure 2. Results of the student satisfaction survey. Results are represented as the percentage 
of the total number of respondents who rated a given aspect at the same level. It is obvious that 
the majority of participants rated all aspects as excellent or good, which signifies a high level of 
satisfaction.  
 
 
As for the descriptive evaluations, they could be divided into two large groups: those 
which expressed students’ satisfaction with the course and those making technical 
suggestions. The first group included comments like “I found it very useful. Actually, 
students on the general medicine track should take this course as well” or “What I liked 
about this course is that it deals with a completely new topic, which has not been dealt 
with before in the official curriculum. What is more, we can use what we have learnt not 
only in our dental practice, but in our private lives as well” and “Now I understand 
why it is difficult for smokers to give up tobacco use!” Typical comments from the 
second group are  
“Real smokers should be involved in the course, so that we would have a direct chance 
to ask them how they feel about the way we communicate” or “A wider variety of 
scenarios for the video sessions would be useful.” 
Finally, it is important to point out that the ratings of the corresponding points on the 
student evaluation forms filled by course teachers and actors largely overlapped.  
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4.2.5. A discussion of the findings 
 
Although the course is too recent to be evaluated in terms of actual cessation support 
efficacy, student feedback shows that it was welcome and possibly filled a long-
standing void experienced by students too. That is, student responses revealed that there 
exists a communicative gap between smokers and non-smokers in connection with 
smoking (“Real smokers should be involved…”; “Now I understand why...”), which is 
possibly related to the increasing (also legal) stigmatization of smoking on one hand 
and the lack of ongoing professional communication on the other. That smoking is 
something “bad” is increasingly and righteously realized, however, at the same time, 
smokers possibly perceive stigmatization, which may make them hide their habit or feel 
guilty about it, so that finally they will rather not talk to their dentist about their 
tobacco-related problems. This is just complicated by the fact that dentists who 
themselves smoke will shy away from the topic too, possibly so as not to lose patients’ 
respect. One might say that tobacco-related popular communication operates mostly at 
the emotional level, inducing an uncertain and maybe uncanny feeling that there is 
“something wrong” with people who smoke. We believe that a key aspect in 
professional tobacco prevention is that tobacco use should not be demonized as a 
personality defect. Prevention and cessation counseling require an atmosphere of 
unconditional acceptance based on firm scientific knowledge of the multifactorial 
nature of tobacco dependence and also a firm knowledge of the most efficient methods. 
It is against such a background that efficient patient education and cessation support can 
happen. We are positive that our course is a step toward that goal.  
The survey and written feedback show that the novel aspect of this course, simulation 
with videofeedback, turned out to be a great success.  Obviously, this method gives a 
“closest to the real thing” experience, one step beyond training in pairs with peers, but 
still without the risks of working with real patients. This means a smoother transition 
from the classroom to reality with the chance of learning about one’s strengths and 
weaknesses, supported by professional feedback. It is very important to emphasize that 
teacher observations on student performance largely overlapped with actor ratings, 
which indicated that video recording offers an optimal tool of evaluation.     
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We have learned a lot from students’ direct personal reactions during the course as well. 
For instance, students who had taken the course admittedly only because they needed 
credits became interested and actively involved by the end of the sessions. More 
importantly, we know about students who quit smoking under the influence of the 
course, which is a very important, if unplanned effect - as the course was not directed at 
student cessation. A third, and not less important observation was that, as they were 
learning about smoking in detail, participants gradually gave up their “blaming” attitude 
towards smokers, and they finally became able to establish a rapport that was optimal 
for behavioral interventions.    
Pieces of student feedback suggesting technical changes are being considered, and they 
will be used for the further development of the course, whenever possible.       
In conclusion, our recently introduced tobacco prevention and cessation counseling 
course for undergraduate students has been successful in several respects.  
First and foremost, it was almost unequivocally popular with students, who welcomed it 
as a long missed, interesting and useful curricular element. This means that students 
were actually interested in what was taught, which is obviously a factor that increases 
the success of knowledge and skills transfer. 
Second, the reactions of students corroborated our conviction that in order to increase 
the efficacy of professional cessation help efforts, “serious talk” about smoking is 
essential, to take these efforts beyond the popular imagery of fighting against some 
widely defined evil, and to get rid of the communicative block resulting from the 
stigmatization of smoking.  A course like ours offers facts, evidence-based methods and 
the chance to put the newly acquired knowledge to the test immediately. This latter 
element makes the whole process a very intense learning experience.  
Third, simulation with video feedback, the key element of our new course, has proven 
to be a very useful method.  By its introduction it became possible for students to gain 
next-to-real experience with counseling and to have professional feedback on their 
performance, without risking real-life consequences. It also turned out that the video 
recordings can be used very well to assess how well a particular student is doing, as 
video-based teacher ratings largely overlapped with the ratings of actor questionnaires. 
Fourth, by using standard questionnaires administered to actual patients, each student 
can monitor their own development from time to time, and thus the long-term efficacy 
of the course can be assessed as well.      
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Finally, we believe that the introduction of this course into the curriculum of the Faculty 
of Dentistry at the University of Szeged has filled a long-standing void, and we are also 
positive that the actual cessation support efficacy results will corroborate its usefulness. 
At the same time we suggest that simulation with video feedback can be a very strong 
element of any behavioral intervention program, as it offers the chance to put theory 
into practice immediately, but without the risks of immediate real-life application. 
Therefore, we believe that this methodology should be an integral part of tobacco 
intervention teaching methodologies.    
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5. Thesis summary and recapitulation 
 
Rolling back tobacco-related oral diseases, or at least keeping them at bay is a task of 
utmost importance in a country which occupies a leading position in terms of  both 
tobacco-related mortality and the number of oral cancer cases. The task is immense, and 
the possible approaches are countless. In this thesis, two examples from our recent work 
in the field have been presented, which are tiny steps in the whole process, but we do 
believe that such tiny steps add up to real solutions.  
The fact that one does dentistry at a university faculty puts one at a double advantage: 
one is that one has access to the infrastructure to do research and gain a deeper 
understanding of phenomena, and the other is that one can disseminate knowledge and 
shape future dentists’ understanding of those phenomena. 
Therefore, the examples chosen for the purposes of this thesis came from these two 
major segments of university work.   
As for the research segment, we showed that smoking puts psoriasis patients at a 
massively increased risk of severe periodontal disease, the immediate message of which 
is that such patients should stay away from smoking as much as they can, so that further 
deterioration of their already poor health and quality of life can be prevented. At the 
level of scientific interpretation, this result points to the massive immunomodulatory 
capacity of cigarette smoke, and marks the path for further research into how cigarette 
smoke can give rise to secondary pathology in chronic inflammatory conditions.  
In the second part of the thesis, an entirely new university course was introduced, which 
was developed at our faculty in order to enable students to provide tobacco cessation 
support and also to address the problem of high levels of smoking among oral health 
professionals. This course - now offered in two consecutive semesters- is based on a 
complex approach, that is, a strong theoretical priming is completed by skills training 
and practice. A central element of the practical part is videofeedback, which we were 
the first to introduce into the methodology of cessation support training. The initial 
results are promising, and although it would be too early to say about anything about the 
efficacy of the programme in terms of actual quit rates, the change in student attitudes 
can be felt already.  
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These results set the directions for the years to come, and the work goes on in the firm 
belief that even if smoking is a disease of mankind one cannot ultimately cure, one must 
still care.                                                                  
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